1. Individualised therapy is more cost-effective than dose intensification in patients with Crohn's disease who lose response to anti-TNF treatment: a randomised, controlled trial. Issue 6 (22nd July 2013) Authors: Steenholdt, Casper; Brynskov, Jørn; Thomsen, Ole Østergaard; Munck, Lars Kristian; Fallingborg, Jan; Christensen, Lisbet Ambrosius; Pedersen, Gitte; Kjeldsen, Jens; Jacobsen, Bent Ascanius; Oxholm, Anne Sophie; Kjellberg, Jakob; Bendtzen, Klaus; Ainsworth, Mark Andrew Journal: Gut Issue: Volume 63:Issue 6(2014) Page Start: 919 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗